Johnson & Johnson
BASEJohnson & Johnson has done something quietly remarkable this week: it has rallied far enough that the stock now trades above every single price at which its executives have sold over the past three weeks. The insider theme that dominated the last two notes has not resolved — it has simply been outrun by the tape. CEO Joaquin Duato disposed of roughly $44.7 million worth of stock…
Snapshot as of 23 Sept 2026
Johnson & Johnson has done something quietly remarkable this week: it has rallied far enough that the stock now trades above every single price at which its executives have sold over the past three weeks. The insider…
Johnson & Johnson is finding its footing after last week's retreat, but the borrow cost anomaly that defined the prior note has not resolved — and that tension remains the most interesting thread heading into October…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JNJ — free to start on ORTEX.
Sign up for free →Open JNJ on ORTEX